Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,535 recalls, newest first.

Class II · Moderate risk

Biest Cp 80/20

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Terminated Cross-contamination the Compounder D-0186-2016
Class II · Moderate risk

Biest Cp 80/20

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Terminated Cross-contamination the Compounder D-0185-2016
Class II · Moderate risk

Biest Cp 76/24: Dhea

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Terminated Cross-contamination the Compounder D-0184-2016
Class II · Moderate risk

Fomepizole Injection

Lack of Assurance of Sterility. A recent FDA inspection reported GMP violations potentially impacting product quality and sterility.

Terminated Sterility / contamination Navinta LLC NDC 0781-3182-73 D-0431-2015
Class II · Moderate risk

5% DEXTROSE Injection

Lack of Assurance of Sterility: there is a potential for solution to leak at the administrative port of the primary container.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7100-02 D-0417-2015
Class II · Moderate risk

Haloperidol Oral Solution

Defective Container: Confirmed customer complaints of leaking bottles.

Terminated Packaging defect Safecor Health, LLC NDC 54838-0501-40 D-0661-2016
Class II · Moderate risk

RIFAMPIN for Injection

Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

Terminated Sterility / contamination Heritage Pharmaceuticals, Inc. NDC 23155-340-31 D-0416-2015
Class II · Moderate risk

Colistimethate for Injection USP

Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

Terminated Sterility / contamination Heritage Pharmaceuticals, Inc. NDC 23155-193-31 D-0415-2015
Class II · Moderate risk

Atracurium Besylate Injection

Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

Terminated Sterility / contamination Sagent Pharmaceuticals Inc NDC 25021-672-10 D-0399-2015
Class II · Moderate risk

Atracurium Besylate Injection

Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.

Terminated Sterility / contamination Sagent Pharmaceuticals Inc NDC 25021-659-05 D-0398-2015
Class II · Moderate risk

Phen 15 mg - Topri 92 mg SR Cap

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D1051-2015
Class II · Moderate risk

Hydrocortisone 1.6 mg/0.5 mL Susp

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1062-2015
Class II · Moderate risk

Nystatin 50

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1061-2015

Recalls by year